SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Tesaro, Inc. (TSRO)

TSRO RSS Feed
Add TSRO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/27/2017 10:21:08 PM - Followers: 12 - Board type: Free - Posts Today: 0

Board discussion should pertain only to TSRO.
SureTrader
Interactive Brokers Advertisement
TSRO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
TSRO News: TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany 04:00 AM
TSRO News: Current Report Filing (8-k) 12/06/2017 12:28:59 PM
TSRO News: Statement of Changes in Beneficial Ownership (4) 12/05/2017 06:11:02 PM
TSRO News: Confidential Treatment Order (ct Order) 12/04/2017 09:32:40 AM
TSRO News: TESARO Announces Availability of VARUBI® (rolapitant) IV for Delayed Nausea and Vomiting Associated With Cancer Chemotherapy... 11/28/2017 08:00:00 AM
News News Alert: TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany 12/15/2017 04:00:00 AM
PostSubject
#93   $TSRO Tesaro, Inc. https://www.barchart.com/story/stocks/quotes/OTIC/39 MazelTov 09/27/17 10:21:08 PM
#92   Tsaro Announces Availability of Zejula™ (Niraparib) for Patients tomsylver 04/20/17 03:27:27 AM
#91   The FDA approved it. IPO$ 03/28/17 07:56:02 AM
#90   FDA approval!!! IPO$ 03/28/17 07:55:44 AM
#89   March Presentation for Raymond James 38th Annual Institutional tomsylver 03/08/17 04:09:23 AM
#88   TESARO's (TSRO) CEO Lonnie Moulder on Q4 2016 tomsylver 03/01/17 02:18:28 PM
#87   Clovis Oncology’s Ovarian Cancer Drug Faces Stiff Competition trendmkr 01/31/17 06:59:44 PM
#86   The Three Most Important Questions For TESARO Inc trendmkr 01/13/17 12:01:27 PM
#85   TESARO Receives Complete Response Letter for Rolapitant IV tomsylver 01/12/17 04:15:13 AM
#84   Here’s Another Discount Entry Opportunity: TESARO trendmkr 11/16/16 02:52:15 PM
#83   Here’s Another Discount Entry Opportunity: TESARO trendmkr 11/16/16 02:52:14 PM
#82   Q3 datas: TESARO ANNOUNCES THIRD-QUARTER 2016 OPERATING RESULTS Niraparib roll tomsylver 11/03/16 04:13:37 PM
#81   Data presentation of niraparib (NOVA) at IGCS WALTHAM, Mass., tomsylver 11/01/16 04:38:46 AM
#80   What Promise Does Tesaro's Candidate Niraparib Hold? trendmkr 10/11/16 12:25:15 PM
#79   TSRO is a great $$$$$ opportunity. crudeoil24 10/10/16 09:43:44 AM
#78   long-term STOCK account scan TSRO bullish 108.59 stocktrademan 09/25/16 07:27:58 PM
#77   TSRO bullish 108.09 stocktrademan 09/22/16 09:52:57 AM
#76   Forget Sarepta Therapeutics, Here Are 3 Other Biotech tomsylver 09/21/16 01:34:39 AM
#75   Looking Ahead To The Potentially Game Changing TESARO trendmkr 09/14/16 11:57:30 AM
#74   Tesaro, Inc. TSRO announced that the FDA has tomsylver 09/13/16 06:28:51 PM
#73   5 very interesting posts... tomsylver 09/08/16 05:01:26 PM
#72   TSRO $96.10 HOD ClearlyStocks 09/08/16 12:55:40 PM
#71   TSRO $95.44 way too fast ClearlyStocks 09/08/16 10:21:04 AM
#70   TSRO $94.88 ClearlyStocks 09/08/16 10:20:22 AM
#69   TSRO $93.76 ClearlyStocks 09/08/16 10:20:10 AM
#68   TSRO $92 what a runner ClearlyStocks 09/08/16 10:19:27 AM
#67   TESARO (NASDAQ:TSRO) initiated with Outperform rating and $122 tomsylver 08/19/16 05:08:32 PM
#66   Tesaro Q2 results on August 4, 2016 WALTHAM, Mass., tomsylver 07/24/16 04:19:15 AM
#65   TSRO bullish 88.05 stocktrademan 07/17/16 08:42:23 PM
#64   ENGOT and TESARO Partnership Generates Positive Data The ENGOT-OV16/NOVA tomsylver 07/08/16 04:33:16 PM
#62   A Big Breakthrough for Ovarian Cancer Patients Tesaro's PARP-inhibitor tomsylver 07/03/16 02:25:43 PM
#61   Why would there be a squeeze if they're T695 07/01/16 08:31:57 AM
#60   What a squeeze coming! All the remaining shorts jones99 07/01/16 04:39:58 AM
#59   Not today we won't T695 06/30/16 08:00:42 AM
#58   TESARO Announces Proposed Public Offering of Common Stock Source: T695 06/30/16 06:49:15 AM
#57   Point72 Accumulating TSRO https://fintel.io/soh/us/tsro/point72-asset-management http wiltonio 06/30/16 01:37:13 AM
#56   Approximately 40% of the outstanding shares were traded tomsylver 06/29/16 04:49:01 PM
#55   I think so too, got some Aug 19 RTMidgetman 06/29/16 02:56:08 PM
#54   Cmon and break 75 T695 06/29/16 02:52:52 PM
#53   1 mio Profit MasterbrokerUSA 06/29/16 11:45:52 AM
#52   This going to get shorted back down some doon T695 06/29/16 11:09:27 AM
#51   Squeeeeezzzzzzeeeeee The Market Maker 06/29/16 11:01:24 AM
#50   Dam T695 06/29/16 10:35:29 AM
#49   TESARO Announces Rolapitant Data Presentations at the 2016 tomsylver 06/24/16 05:06:31 AM
#48   Rolapitant IV NDA accepted for review by FDA; tomsylver 06/05/16 09:53:05 AM
#47   TESARO (NASDAQ:TSRO) initiated with Outperform rating and $56 tomsylver 05/23/16 02:42:12 PM
#46   TESARO Announces Validation of Marketing Authorisation Application for tomsylver 03/23/16 10:50:38 AM
#45   TESARO Submits New Drug Application for Intravenous Rolapitant tomsylver 03/14/16 10:19:41 AM
#44   Transcript of TSRO cc http://finance.yahoo.com/news/edited-transcript-tsro-ear tomsylver 02/27/16 02:45:38 AM
#43   Tesaro to Announce Fourth Quarter 2015 Financial Results tomsylver 02/11/16 04:25:27 PM
PostSubject